Source: European heart journal. Unidade: FM
Subjects: TROMBOSE, SEXO, SÍNDROME CORONARIANA AGUDA, PLAQUETAS SANGUÍNEAS
ABNT
HUSTED, Steen et al. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. European heart journal, v. 35, n. 23, p. 1541-1550, 2014Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehu075. Acesso em: 09 out. 2024.APA
Husted, S., James, S. K., Bach, R. G., Becker, R. C., Budaj, A., Heras, M., et al. (2014). The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. European heart journal, 35( 23), 1541-1550. doi:10.1093/eurheartj/ehu075NLM
Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, Himmelmann A, Horrow J, Katus HA, Lassila R, Morais J, Nicolau JC, Steg G, Storey RF, Wojdyla D, Wallentin L. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial [Internet]. European heart journal. 2014 ; 35( 23): 1541-1550.[citado 2024 out. 09 ] Available from: https://doi.org/10.1093/eurheartj/ehu075Vancouver
Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, Himmelmann A, Horrow J, Katus HA, Lassila R, Morais J, Nicolau JC, Steg G, Storey RF, Wojdyla D, Wallentin L. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial [Internet]. European heart journal. 2014 ; 35( 23): 1541-1550.[citado 2024 out. 09 ] Available from: https://doi.org/10.1093/eurheartj/ehu075